Latest Articles

  • How do we maximize diuresis in acute decompensated heart failure?
    Saeid Mirzai, DO, Christopher N. Kanaan, MD, Felix Berglund, MD, Maria Mountis, DO and Heba Wassif, MD, MPH
    Cleveland Clinic Journal of Medicine October 2022, 89 (10) 561-565; DOI: https://doi.org/10.3949/ccjm.89a.22016

    The initial goal is to maximize loop diuretic therapy using urine output or urinary sodium for guidance. Combination therapy can be used when patients respond poorly to escalating loop diuretic doses.

  • Blue sclera: An overlooked finding of iron deficiency
    Yasuhiro Kano, MD
    Cleveland Clinic Journal of Medicine October 2022, 89 (10) 549-550; DOI: https://doi.org/10.3949/ccjm.89a.22045

    The pathogenesis is thought to involve thinning of collagen fibers of the sclera due to iron deficiency, allowing the bluish color of the underlying uvea to become visible.

  • Diagnostic stewardship for urinary tract infection: A snapshot of the expert guidance
    Glenn T. Werneburg, MD, PhD and Daniel D. Rhoads, MD
    Cleveland Clinic Journal of Medicine October 2022, 89 (10) 581-587; DOI: https://doi.org/10.3949/ccjm.89a.22008

    New guidance on ordering, processing, and reporting urine cultures focuses on reducing unnecessary antibiotic use and the misdiagnosis of urinary tract infection.

  • A 65-year-old man with melena and a blood disorder
    Monia E. Werlang, MD, Marilia L. Montenegro, MD and Bhaumik Brahmbhatt, MD, MBBS
    Cleveland Clinic Journal of Medicine October 2022, 89 (10) 573-578; DOI: https://doi.org/10.3949/ccjm.89a.20175

    The patient had chronic anemia related to primary myelofibrosis and was being treated with epoetin alfa and ruxolitinib, with blood transfusions every other week.

  • The role of GLP-1 receptor agonists in managing type 2 diabetes
    Cleveland Clinic Journal of Medicine October 2022, 89 (10) 597;

    The following article in the August 2022 issue contained an error: Nachawi N, Rao PP, Makin V. The role of GLP-1 receptor agonists in managing type 2 diabetes. Cleve Clin J Med 2022; 89(8): 457–464. doi:10.3949/ccjm.89a.21110

  • Mucormycosis presenting as dental pain
    Pankaj Garg, MS, MBBS, Aalam Sohal, MD and Sankalp Mittal, MDS
    Cleveland Clinic Journal of Medicine October 2022, 89 (10) 553-555; DOI: https://doi.org/10.3949/ccjm.89a.22001

    A root canal procedure failed to relieve the pain, and 1 week later the patient developed mobility of the left upper teeth.

  • Widespread skin-thickening and hyperpigmentation
    India K. Poetzscher, Nikolai Klebanov, MD and Shinjita Das, MD, MPH
    Cleveland Clinic Journal of Medicine September 2022, 89 (9) 485-487; DOI: https://doi.org/10.3949/ccjm.89a.21099

    A 37-year-old military veteran presented with extensive velvety hyperpigmented plaques over nearly 15% of the total body surface.

  • Diversifying medical humanities: The case for Jay-Z
    Alok A. Khorana, MD
    Cleveland Clinic Journal of Medicine September 2022, 89 (9) 501-503; DOI: https://doi.org/10.3949/ccjm.89a.22011

    Physicians carry considerable power in the patient-physician relationship. Opening our minds to the viewpoints of others diffuses some of that power and grounds us in the communities we serve.

  • Balancing the myths of corticosteroid therapy
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2022, 89 (9) 480-481; DOI: https://doi.org/10.3949/ccjm.89b.09022

    No class of drug has more mythical attributes, interfaces with different medical specialties, or clinical street lore than corticosteroids.

  • Hyperpigmentation as a clue to Addison disease
    Yusuke Hirota, MD, PhD and Takaya Matsushita, MD, PhD
    Cleveland Clinic Journal of Medicine September 2022, 89 (9) 498-499; DOI: https://doi.org/10.3949/ccjm.89a.21082

    The 66-year-old woman presented with fatigue, loss of appetite, and hyperpigmentation of the tongue, soft palate, buccal mucosa, lower lip, fingers, and nail beds.

Pages